- Efficacy and Safety of Oral Non‐Statin Lipid‐Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta‐Analysis
Endocrinology Diabetes & Metabolism · 2026
- Treat-to-target strategies for low-density lipoprotein cholesterol and triglyceride levels for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia
Cochrane Database of Systematic Reviews · 2026
- Resmetirom attenuates atherosclerosis-associated dyslipidemia and vascular inflammation in high-fat diet-fed ApoE−/− mice
PLoS ONE · 2026
- Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome.
2026
- Pharmacological lipid-lowering therapies for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia: a systematic review and network meta-analysis
Cochrane Database of Systematic Reviews · 2026
- Real world patterns of dyslipidemia care before and after a national fee revision in Japan: A nationwide study using a 30 million patient claims database
PLoS ONE · 2026
- Changes in LDL-C levels among primary health care patients with hypertension, coronary artery disease, and diabetes during a 36-month follow-up
Scandinavian Journal of Primary Health Care · 2026
- Clinical inertia in cardiovascular risk management: prevalence, associated factors, and impact on outcomes of the OPM study
Journal of Global Health · 2026
- Joint assessment of triglyceride-glucose index and non-traditional lipid parameters for incident stroke risk in middle-aged and older chinese adults: A prospective cohort study based on CHARLS
Journal of Stroke and Cerebrovascular Diseases · 2026
- Trends in mortality involving co-reported arrhythmia and dyslipidemia, 1999–2023: A Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research analysis with exploratory projections to 2035
Journal of International Medical Research · 2026
- Dose-stratified lipid-lowering efficacy and safety of oral PCSK9 inhibitors: a systematic review and meta-analysis
Journal of Cardiovascular Medicine · 2026
- LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction
JAMA · 2026
- The mediating role of cardiac autonomic imbalance in the association between hypoxic burden and dyslipidemia in obstructive sleep apnea
Annals of Medicine · 2026
- Cardiometabolic risk profile and associated factors among adults with type 2 diabetes in a primary health care clinics in North Central Nigeria
African Journal of Primary Health Care & Family Medicine · 2026
- A Cross-Sectional Analytical Study: Prevalence and Clinical Profile of Metabolic Syndrome Among Middle Eastern, Mainly Jordanians, Cohort Presented with Atherosclerotic Cardiovascular Disease
Vascular Health and Risk Management · 2026
- Correspondence- Muscle Magnetic Resonance Imaging Phenotyping and Pattern Recognition in Genetically Confirmed Myopathies: A Large-Cohort Study from the Indian Subcontinent
Annals of Indian Academy of Neurology · 2026
- Dyslipidemia and Hypertension: Management Issues
2026
- Socio-demographic and clinical determinants of dyslipidaemia in hypertensive patients at the Effia Nkwanta Hospital; a cross-sectional study
Scientific Reports · 2026
- Association between the atherogenic index of plasma trajectory and risk of cardiovascular diseases among hypertensive patients: a prospective cohort study
Cardiovascular Diabetology – Endocrinology Reports · 2026
- Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies
Frontiers in Cardiovascular Medicine · 2026
- Gender-specific age inflection points for hypertension, elevated fasting blood glucose, and dyslipidemia in a Northern Chinese cohort: a comorbidity-based analysis
BMC Public Health · 2026
- Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis
Frontiers in Cardiovascular Medicine · 2026
- Alternate-day vs. daily dosing of rosuvastatin: a meta-analysis of its efficacy in lowering lipid profile levels
The Egyptian Journal of Internal Medicine · 2026
- Drugs for Hypercholesterolemia
The medical letter on drugs and therapeutics/The medical letter · 2026
- Identifying high-risk and actionable profiles for prevention in hypertensive patients with concurrent dyslipidemia: a population-based retrospective study
BMC Cardiovascular Disorders · 2026
- 1655-P: Where Fat Is Stored Matters More than How Much: A Large-Scale Population-Based Study Integrating DXA Phenotyping and Causal Inference
Diabetes · 2026
- 1446-P: MiRNA-103 as a Potential Therapeutic Inhibitor of Dyslipidemia through Modulation of the ANGPTL8/ANGPTL3 Axis
Diabetes · 2026
- 1452-P: Adipose Tissue Insulin Resistance: Associated Factors and Sex Differences across Obesity and Dyslipidemia Status
Diabetes · 2026
- Impact of Lipid Status on Environmental Quality of Life and Mood Disorders Among Diabetic Cohorts
NATIONAL BOARD OF EXAMINATIONS JOURNAL OF MEDICAL SCIENCES · 2026
- Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals
Nutrition Metabolism and Cardiovascular Diseases · 2026
- Beyond performance: uncovering cardiometabolic and imaging profiles in female athletes
European Journal of Preventive Cardiology · 2026
- Cardiovascular risk profile in Japanese Olympic athletes
European Journal of Preventive Cardiology · 2026
- PCSK9 inhibitor therapy and 1-year risk of incident heart failure among adults with dyslipidaemia and coronary artery disease: a propensity-matched cohort study
European Journal of Preventive Cardiology · 2026
- Beyond the SCORE2: unveiling the hidden links between cardiovascular risk and cognition, health literacy, quality-of-life in dyslipidemia
European Journal of Preventive Cardiology · 2026
- Baseline dyslipidemia in treatment-naïve breast cancer: Molecular subtype–specific patterns in a large cohort.
Journal of Clinical Oncology · 2026
- Editorial: New drugs in lipid lowering therapy
Frontiers in Cardiovascular Medicine · 2026
- Sex Patterns of Statin Therapy and Multicomponent Exercise Training on Cardiorespiratory Fitness in Older Adults with Dyslipidemia: A 24-Month Cohort Study
Sports · 2026
- Atherogenic index of plasma as a predictor of cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries
Scientific Reports · 2026
- Interplay of Multipathway Dyslipidemia, Inflammation, and Cholesterol-Lowering Medication in Modifying Abdominal Aortic Aneurysm Risk
Arteriosclerosis Thrombosis and Vascular Biology · 2026
- Joint effects of dyslipidemia and the platelet count on stroke risk: Longitudinal analysis via dynamic lipid stratification in the CHARLS cohort
BMC Neurology · 2026
- The Effect of Angiotensin (1-7) on Serum Metabolomics in Obese Type 2 Diabetic Mice
Metabolites · 2026
- Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China
Frontiers in Cardiovascular Medicine · 2026
- Impact of a mobile health education program on blood pressure and lipid profiles: a cohort study
BMC Public Health · 2026
- Association of epicardial adipose tissue thickness and left ventricular functions in children with primary dyslipidemia
European Journal of Pediatrics · 2026
- Management of dyslipidaemia in patients with comorbidities – facing the challenge: Heart failure
European Heart Journal - Cardiovascular Pharmacotherapy · 2026
- ABSTRACT NUMBER: ESOC2026A1595 COMBINED LIPID-LOWERING THERAPY WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH ISHEMIC STROKE AND DYSLIPIDEMIA: A RETROSPECTVE ANALYSIS
European Stroke Journal · 2026
- Impact of Cardiometabolic Risk Markers on the Incidence and Progression Arterial Stiffness in Patients With Prediabetes
Journal of Diabetes · 2026
- COMPARATIVE ASSESSMENT OF THE IMPACT OF POLYPILL THERAPY VERSUS SEPARATE DRUG ADMINISTRATION ON TREATMENT ADHERENCE AND MYOCARDIAL STRUCTURAL REMODELING
Journal of Hypertension · 2026
- POLYPILL STRATEGY REVEALS A HIDDEN ADHERENCE–RISK SIGNAL IN HIGH-RISK HYPERTENSION
Journal of Hypertension · 2026
- TRIGLYCERIDE–GLUCOSE INDEX LINKS LIPID ATHEROGENICITY, BLOOD PRESSURE, AND ARTERIAL STIFFNESS IN MALE PATIENTS WITH HIGH CARDIOVASCULAR RISK
Journal of Hypertension · 2026